Growth differentiation factor 11: a "rejuvenation factor" involved in regulation of age-related diseases?

Aging (Albany NY). 2021 Apr 22;13(8):12258-12272. doi: 10.18632/aging.202881. Epub 2021 Apr 22.

Abstract

Growth differentiation factor 11 (GDF11), a member of the transforming growth factor β superfamily of cytokines, is a critical rejuvenation factor in aging cells. GDF11 improves neurodegenerative and neurovascular disease outcomes, increases skeletal muscle volume, and enhances muscle strength. Its wide-ranging biological effects may include the reversal of senescence in clinical applications, as well as the ability to reverse age-related pathological changes and regulate organ regeneration after injury. Nevertheless, recent data have led to controversy regarding the functional roles of GDF11, because the underlying mechanisms were not clearly established in previous studies. In this review, we examine the literature regarding GDF11 in age-related diseases and discuss potential mechanisms underlying the effects of GDF11 in regulation of age-related diseases.

Keywords: GDF11; age-related diseases; aging; growth differentiation factor 11; regeneration; transforming growth factor.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aging / drug effects
  • Aging / metabolism*
  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / genetics
  • Alzheimer Disease / pathology
  • Animals
  • Bone Morphogenetic Proteins / administration & dosage*
  • Bone Morphogenetic Proteins / genetics
  • Bone Morphogenetic Proteins / metabolism*
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / genetics
  • Cardiovascular Diseases / pathology
  • Cellular Senescence / drug effects
  • Cellular Senescence / physiology
  • Disease Models, Animal
  • Growth Differentiation Factors / administration & dosage*
  • Growth Differentiation Factors / genetics
  • Growth Differentiation Factors / metabolism*
  • Humans
  • Longevity / physiology
  • Mice
  • Muscle Strength / drug effects
  • Muscle Strength / physiology
  • Muscle, Skeletal
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / genetics
  • Rejuvenation*
  • Sarcopenia / drug therapy
  • Sarcopenia / genetics
  • Sarcopenia / pathology
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Stroke / drug therapy
  • Stroke / pathology

Substances

  • Bone Morphogenetic Proteins
  • GDF11 protein, human
  • Gdf11 protein, mouse
  • Growth Differentiation Factors
  • Recombinant Proteins